German Leisure Stock News

Adidas (XTRA:ADS) is back under scrutiny after a local Single Shoe advertising campaign featuring former Israeli soldier Shalev Biton drew criticism, sparked boycott calls, and prompted apologies from Adidas units in Israel and Arabia. At a share price of €146.45, adidas has seen the 1 month share price return fall 12.49% and the 3 month share price return decline 15.49%, while the 1 year total shareholder return is down 16.35%. This suggests recent sentiment has weakened even as headlines...

DWS Group GmbH KGaA (XTRA:DWS) has set a clear marker for its future identity. The asset manager plans to rebrand globally as Deutsche Asset Management from November 2026, unifying operations under one banner. DWS Group GmbH KGaA shares trade at €77.1, with a 7 day share price return of 3.35% and a 90 day gain of 33.28%. This lines up with a strong 1 year total shareholder return of 56.59%, suggesting momentum has been building as the rebrand story has taken shape. Compare the rebrand-driven...

Biotest GmbH KGaA (HMSE:BIO0) is back in focus after fresh industry commentary highlighted its Trimodulin candidate among emerging therapies in community-acquired bacterial pneumonia, drawing attention to the company’s role in this specific treatment niche. Set against the Trimodulin headlines, Biotest GmbH KGaA’s share price sits at €33.2 with a 90‑day share price return of 3.11% and year to date gain of 5.06%, while the 12.30% total shareholder return over one year points to gradually...

Deutsche Börse AG has completed a €600 million fixed to floating rate senior, subordinated, unsecured bond offering, with callable variable coupon notes maturing in September 2052. The 26 year fixed income deal extends Deutsche Börse’s funding profile and adds long dated, flexible interest cost to support its market infrastructure and data ambitions. With this €600 million fixed income issuance now in place, we can assess how the new long dated funding shapes Deutsche Börse's investment...

Bayer reported detailed Phase III REVEAL data for its investigational PET radiotracer iodine 124 evuzamitide in cardiac amyloidosis, showing high sensitivity and specificity across AL and ATTR subtypes and a generally manageable safety profile in 170 evaluated adults. The compound already holds Breakthrough Therapy and Orphan Drug designations, so positive diagnostic accuracy data could strengthen Bayer’s late stage pipeline story in specialized cardiovascular imaging. We will now look at...

LANXESS (XTRA:LXS) has put its new tire additive Vulkanox 4060 in the spotlight after securing EU REACH registration. The company is positioning the compound as an environmentally oriented alternative to 6PPD for European producers. LANXESS shares trade at €15.46, with a 1-day share price return of 1.05% and a 7-day share price return of 2.86%, yet the year-to-date share price return is down 11.76% and the 1-year total shareholder return has declined 33.38%, pointing to fading long-term...

Infineon Technologies has delivered an 85.0% return over the past three years, yet current checks suggest the stock now trades close to what a Discounted Cash Flow (DCF) based intrinsic value estimate would call fair rather than clearly cheap. The 85.0% gain over three years leaves existing holders sitting on strong headline returns, which raises the bar for fresh buyers looking for value. Infineon Technologies features as a key supplier in the growing avalanche breakdown diodes market that...

Deutsche Bank’s inflation warning as a fresh equity signal Deutsche Bank (XTRA:DBK) has put inflation risk back on the table. In its latest dislocations report, the lender argues that comfort around prices, rates and growth now rests on fragile assumptions. The report points to a squeeze from rising energy, food and commodity costs just as investors are pricing in steady conditions across bonds, equities and credit. That situation is the starting point for reassessing Deutsche Bank...

Commerzbank has launched a tender offer for up to €750,000,000 of its outstanding Additional Tier 1 notes and recently completed a €997.91m fixed income issue, as part of a wider capital and funding reshuffle that began in late August 2026. The combination of the €1.2b share buyback, targeted AT1 repurchases and fresh senior funding shows Commerzbank actively reconfiguring its capital stack and interest cost profile rather than relying solely on future earnings growth. With Commerzbank using...

SAP stock has delivered a solid 61.8% gain over the past 5 years, yet current valuation checks send a more cautious message, with the intrinsic value estimate pointing to meaningful upside while the share price has recently come under pressure. Recent drawdowns and a mixed overall value score leave SAP looking potentially cheap on some measures, but not an obvious across the board bargain. The 61.8% return over 5 years suggests SAP has rewarded patient holders, which makes any current...

Sales reorganisation puts Porsche in focus Dr. Ing. h.c. F. Porsche (XTRA:P911) has moved to restructure its global Sales and Marketing division, consolidating sales regions and dissolving several central departments to push more responsibility into local markets. The plan reduces the current setup from five sales regions to four, folds Germany into a broader Europe hub, and combines North, Central and South America into a single Americas region under Porsche Cars North America chief Timo...

A surge in support for Germany’s AfD is shaking assumptions about EU cohesion, euro stability and the future of European security policy. That kind of political friction can quickly reshape where risk and potential reward sit in European markets, especially for defence and security related stocks. This article walks through three stocks exposed to these headlines and explains how the changing backdrop could matter for your portfolio decisions. The stocks covered below are only a sample of...

Europe’s space ambitions just became more real. Isar Aerospace has reached orbit on its second test flight and reports a commercial pipeline above €10b, which underlines how much paying demand is forming around launch capacity. For investors, that kind of pressure on supply can reshape which stocks benefit from the new space race. This article reveals three stocks exposed to this news and explains why each could matter for your portfolio. The three stocks below are just a starting sample. The...

Germany’s latest regional election shock, with surging AfD support and a weaker showing for Chancellor Merz’s CDU, has pushed political risk back onto every investor’s screen. When policy uncertainty climbs, pricing can move faster than fundamentals. That creates chances both to back potential beneficiaries of higher defence and security focus and to sidestep possible losers. This article breaks down three European stocks that screens suggest could be positively exposed to these shifts. The...

The U.S. Food and Drug Administration issued a warning letter to Fresenius Medical Care (XTRA:FME) over significant quality control violations at its Ogden, Utah plant, raising fresh questions for investors about operational risk. At a share price of €39.22, Fresenius Medical Care has seen mixed momentum, with a 1-day share price return of 1.61% but a 30-day share price return that declined 6.73%. The 1-year total shareholder return declined 3.62%, while the 3-year total shareholder return...

UK research labs keep producing world class ideas, yet many of the most promising spinouts still seek capital and buyers abroad. That drift of talent and IP can turn into a hunting ground for large overseas acquirers that are willing to pay for scale, patents and teams. This article looks at three stocks that are exposed to that trend and explains how each could benefit or face pressure as it evolves. These three stocks are just a starting sample, and the full screen surfaced 13 more large...

European industrials are under pressure as warnings of job cuts, tariff disputes and rising Chinese competition unsettle the outlook for factories across the region. Periods of stress can expose weak business models and put a spotlight on companies with stronger automation and productivity stories. This article looks at three European industrial automation and productivity leaders that appear most exposed to the latest EU China trade headlines and explains why these stocks may warrant closer...

Siemens Energy recently secured a contract to build large steam turbines for Rolls-Royce’s small modular nuclear reactors at its Newcastle factory, reviving domestic turbine manufacturing in the UK and adding 550 jobs. This move links Siemens more closely to the UK’s emerging SMR nuclear supply chain, potentially deepening its role in future clean energy infrastructure projects. Next, we’ll explore how Siemens Energy’s new UK SMR turbine role may influence Siemens’ longer-term industrial...

Sixt stock: U.S. airport push puts Dallas and Boise in focus Sixt (XTRA:SIX2) is back on investor radars after Sixt USA added new airport locations at Dallas Love Field and Boise, extending its U.S. network to 58 sites and entering Idaho. Sixt’s latest U.S. airport additions come after a mixed period for the stock, with the share price at €72.15 and a year to date share price return of 1.91%, but a 1 year total shareholder return that declined 10.20% and a 5 year total shareholder return that...

DEUTZ (XTRA:DEZ) stock is back in focus after the company agreed a co operation with Kirloskar Oil Engines Limited to distribute compact under 2 litre engine solutions across Europe and North America. At a share price of €12.84, DEUTZ has seen strong momentum build over 2026, with a 30 day share price return of 24.54% and a year to date share price return of 48.35%. The 3 year total shareholder return of 231.77% reflects a much longer period of strong performance that this new engine co...

With Brussels turning up the heat on social media over extremist and harmful content, trust and safety tools are moving from back office expense to front page issue. That shift could reshape which European software stocks absorb higher compliance costs and which help others manage them. This article walks through three stocks exposed to this news, explaining how their cloud based AI and moderation capabilities could matter for your portfolio. The three stocks below are just a starting sample,...

TUI Blue Hotel Betriebsgesellschaft recently appointed Louise Bates, previously Director of Brand & Products at TUI Hotels & Resorts, as Managing Director alongside Bernd Mäser, while long-time executive Artur Gerber departed the company but remained an adviser. This leadership change brings to the forefront Bates’s track record in shaping hotel concepts such as TUI Sensatori and TUI Sensimar and her close ties with international hotel partners, which could influence how TUI evolves its...

Commerzbank (XTRA:CBK) is back in focus after launching a tender offer for two Additional Tier 1 note issues and setting a €750 million maximum acceptance amount, together with a planned new AT1 issuance. Commerzbank shares have been firming, with a 1-day share price return of 1.11% adding to a 90-day share price return of 13.37%. The 1-year total shareholder return of 33.04% and a very large 5-year total shareholder return suggest that momentum has been building around recent capital actions...

Redcare Pharmacy (XTRA:RDC) is back in focus after the company announced that CEO Olaf Heinrich will step down after three years, including his role on the Managing Board. He will, however, remain available in an advisory capacity. The CEO transition comes at a time when Redcare Pharmacy’s share price has been volatile, with a 1 day share price return of 4.29% but a 7 day share price return down 6.22%. The 90 day share price return of 23.24% contrasts with a 1 year total shareholder return...